Preventing the Financing of Illegal Synthetic Drugs Act
This bill mandates a study by the Government Accountability Office (GAO) to examine how transnational criminal organizations finance the trafficking of synthetic drugs like fentanyl and methamphetamine. The study will analyze business models, online drug markets (including social media and payment apps), money laundering methods, and government efforts to disrupt these illicit financial flows. It directly affects Congress, as the GAO must submit a report detailing findings within one year of the bill's enactment. The bill does not create new laws but aims to identify gaps in combating drug trafficking finance through this targeted analysis.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jul 2023
Committee Review
Floor Vote
President
Introduced Jul 11, 2023
Last action Jul 11, 2023
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Jul 11, 2023
Committee
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
upper
Jul 11, 2023
Introduced
Introduced in Senate
upper
1 primary · 2 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
John Cornyn
RRepublican
Co
Catherine Cortez Masto
DDemocratic
Co
Jacky Rosen
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about S 2227
Scope: US
Hi! I can help you understand S 2227. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline